Stock Events

Stock Events

Xeris Biopharma (2B30.F) Q3 2024 Earnings

8AugConfirmed

Q4 2023

Q2 2024

Q3 2024

-0.13

-0.11

-0.1

-0.08

Details

Expected EPS

-0.08883739783

Actual EPS

-0.091601

Surprise EPS

-0

Surprise Percent

+3.11%

Description

Xeris Biopharma (2B30.F) has reported earnings of -0.091601 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.